TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$13.19M2016: -$22.54M2017: -$65.01M2018: -$52.93M2019: -$61.41M2020: -$81.43M2021: $124.21M2022: -$55.55M2023: -$59.28M2024: -$61.88M2025: -$42.44M-$42.44M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$42.44M+31.4%
2024-$61.88M-4.4%
2023-$59.28M-6.7%
2022-$55.55M-144.7%
2021$124.21M+252.5%
2020-$81.43M-32.6%
2019-$61.41M-16.0%
2018-$52.93M+18.6%
2017-$65.01M-188.5%
2016-$22.54M-70.8%
2015-$13.19M—